Minimally invasive RPLND safe, efficacious in testis cancer

Minimally invasive retroperitoneal lymph node dissection in testicular cancer reduces length of stay while obtaining a perioperative safety profile comparable to that seen with the open procedure, researchers from the University of California, San Diego Health System reported.
Source: Modern Medicine - Category: Journals (General) Source Type: news